At CliniWings, we combine advanced modeling, health outcomes assessment, and cost analysis to deliver comprehensive evidence that supports market access, reimbursement decisions, and value-based healthcare strategies.
In today’s competitive healthcare landscape, demonstrating clinical effectiveness and economic value is critical. Our HEOR services provide stakeholders with the evidence they need to make informed, strategic decisions that benefit both patients and payers.
We combine real-world data, clinical trial evidence, and patient-reported outcomes for a holistic understanding of an intervention’s impact across healthcare systems and stakeholders.
Our team of health economists, analysts, and researchers delivers scientifically rigorous, actionable, and tailored insights for every client objective.
Cost-Effectiveness
Budget Impact
Markov Models
QALYs
Market Access
From cost-effectiveness to comparative effectiveness — our integrated services
cover the full HEOR spectrum.
Assess the economic value of interventions compared to standard care or alternatives, helping stakeholders understand return on investment.
Quantify the short- and long-term financial impact of adopting new therapies across healthcare systems and payer budgets.
Measure and analyze patient-reported outcomes to demonstrate intervention benefits beyond clinical endpoints.
Build Markov models, decision tree models, and simulation frameworks to predict cost, outcomes, and resource utilization over time.
Test various assumptions and scenarios to ensure robust, evidence-based recommendations that hold across conditions.
Evaluate and compare clinical and economic outcomes of multiple treatment options to guide payer and policy decisions.
From reimbursement to competitive advantage — the measurable outcomes our clients rely on.
Let our health economists, analysts, and researchers deliver
scientifically rigorous, actionable insights — helping you achieve
better outcomes for patients and stakeholders alike.
